Ahead Therapeutics - Fighting Autoimmune Diseases https://validator.w3.org/feed/docs/rss2.html Strategic Alliances Team PIPELINE Exciting Breakthrough: Macrophage Role in Antigen-Specific Immune Tolerance Advancing Science: Ahead Therapeutics Heads to IUIS 2025 and Euroanalysis 2025 The company Technology Carmen Martínez Grace Chen Daniela Greco Lidia Almenara Oumaima El Ouahabi Irene Latore Montse Mancera Jorge Plaza Luna Miriam Salvadó Bruna Barneda Zahonero Bernabé Zea Raul Insa Silvia Rodriguez Vidal Antonia Maria Cano Sarabia Daniel Maspoch Marta Vives Pi Marti Dalmases Ahead Therapeutics Successfully Completes Financing Round with Capital Cell US Patent Granted Maria Vila Ahead Therapeutics Secures Public-Private Collaboration Project for Myasthenia Gravis Research Ahead Therapeutics Receives Positive EMA Feedback to Initiate Regulatory Toxicology Studies Interview with our CEO, Martí Dalmases Arnella contact Become a partner of Ahead Therapeutics Ahead Therapeutics round of financing at Capital Cell Biospain 2023 – Ahead Therapeutics News & Media The 25th International Symposium on Advances in ExTech 2023 – Part 2 Team The 25th International Symposium on Advances in ExTech 2023 Ahead Therapeutics Awarded Breakthrough T1D IDDP Grant to Accelerate ASIT Platform Technology Development for Type 1 Diabetes Ahead Therapeutics: Capital Cell Round Bits & Pretzels HealthTech Conference 2023 10th anniversary of COMSER Ahead Therapeutics Conference 2023 Ahead Therapeutics participate in the BIO International Convention – Digital – 2023 – 5 – 8 June Rechipharm partners with Ahead Therapeutics to devolp rare autoimmune disease therapy Ahead Therapeutics will receive a NEOTEC grant Ahead Therapeutics will participate in the Treg Summit – Boston- 20-22 May UB – Ahead Therapeutics collaboration to advance the development of analytical methods for Ahead’s technology platform. Ahead Therapeutics attended the 3rd Antigen-specific immune tolerance summit last February